← Back
$TLSI All transactions

TriSalus Life Sciences, Inc.

C

$ Value

$0

Shares

759,000

Price

$0

Filed

Apr 20

Insider

Name

Frankenius Equity AB

Title

CIK

0001988262

Roles

10% Owner

Transaction Details

Transaction Date

2025-07-31

Code

C

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

6,989,748

Footnotes

Represents shares received upon conversion of the Series A Preferred Stock (the "Preferred Stock") reported in Table II. | Represents conversion price pursuant to an offer (the "Offer") the Company commenced on June 23, 2025, under which all holders of Preferred Stock could exchange their shares of Preferred Stock for Common Stock equal to the sum of the liquidation preference per share price of $10.00 and all accrued and unpaid dividends per share outstanding through August 10, 2027, divided by a $4.00 conversion price per share. | On July 31, 2025, all 230,000 shares of Preferred Stock held by the Reporting Person were converted into 759,000 shares of Common Stock pursuant to the Offer.

Filing Info

Accession No.

0001628280-26-026014

Form Type

4

Issuer CIK

0001826667

Frankenius Equity AB's History

Date Ticker Type Value
2025-07-31 TLSI C $0
2025-07-31 TLSI C $0

Other Insiders at TLSI (90d)

Insider Bought Sold Last
MATLIN DAVID J 2025-07-31
Frankenius Equity AB 2025-07-31